JACQUELINE RUSSELL: Open Payments
NPI 1730742107 · CALAIS, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 21 payments from 11 companies in 2025. Trend: 2023 $134 · 2024 $300 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $173 |
| Exact Sciences Corporation | 4 | $94 |
| Lundbeck LLC | 2 | $61 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| PFIZER INC. | 2 | $41 |
| Verona Pharma, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
Products named: AIRSUPRA, REXULTI, Cologuard Collection Kit, BREZTRI, GVOKE HYPOPEN, The Cologuard Plus Collection Kit, Ohtuvayre, Veozah.
Industry payments across ME — which companies pay providers there.
